LNA-i-miR-221

N/A

Report date: 2024/04/11 14:02:16

Base Information

Drug NameLNA-i-miR-221
Drug Alias NameLNA-i-Mir-221
ClassificationBiologics
Mechanisms of ActionmicroRNA-221 inhibitors
TargetsmicroRNA-221
Therapy Area/IndicationsSolid tumoursMultiple MyelomaCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAzienda Ospedaliera Universitaria Mater Domini, Catanzaro
China Registration ClassN/A

Develop Information

Active CompaniesAzienda Ospedaliera Universitaria Mater Domini, Catanzaro
Inactive CompaniesN/A
Active IndicationsSolid tumoursMultiple MyelomaCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A